Αρχική World News Lack of Immunity Against SARS-CoV-2 in a Large Tertiary Care Centre in...

Lack of Immunity Against SARS-CoV-2 in a Large Tertiary Care Centre in Vienna

The results from a study that aimed to perform serological testing and evaluate SARS-CoV-2 antibody levels in oncological healthcare workers and cancer patients irrespective of COVID-19 symptoms after implementation of institutional safety measures in a large tertiary care hospital in Vienna, Austria indicate low prevalence of anti-SARS-CoV-2 antibodies in both cohorts, thus indicating a lack of immunity against SARS-CoV-2. The findings highlight the need for continuation of strict safety measures to prevent uncontrolled viral spread according Prof. Thorsten Füreder of the Department of Medicine I, Division of Oncology, Medical University of Vienna in Vienna, Austria and colleagues who published their results on 2 September 2020 in the ESMO Open.

The authors wrote that the SARS-CoV-2 seroprevalence in oncological healthcare workers and the cancer patients has significant implications in terms of cancer care delivery and policy-making decisions.

Between 21 March and 4 June 2020, the oncology healthcare workers and cancer patients were tested for total antibodies against SARS-CoV-2 at the Medical University of Vienna. The study team used the Roche Elecsys® Anti-SARS-CoV-2 immunoassay and reactive samples were additionally tested by the Abbott® SARS-CoV-2 IgG test. Oncology healthcare workers had also to complete a questionnaire regarding demographic parameters, travel history and presence of COVID-19 symptoms.

The study team enrolled 62 oncology healthcare workers and 84 cancer patients. In the cohort of oncological healthcare workers, 20 (32.3%) of tested individuals were medical oncologists, 28 (45.2%) oncology nurses and 14 (22.6%) other, e.g. study coordinators. In the patient cohort, most of those tested were on active anticancer treatment (96.4%).

Since the end of February 2020, 26% of the oncology healthcare workers and 6% of cancer patients had symptoms that could be potentially associated with COVID-19. However, anti-SARS-Cov-2 total antibodies were detected in only 2 (3.2%) oncology healthcare workers and in 3 (3.6%) cancer patients. The second assay for anti-SARS-Cov-2 IgG antibodies confirmed the positive result in all oncology healthcare workers and in 2 (2.4%) cancer patients, suggesting an initial assay’s unspecific reaction in only one case.

Specific anti-SARS-CoV-2 antibodies were found solely in individuals after a documented SARS-CoV-2 viral infection, thus supporting the test methods’ high sensitivity and specificity. In persons with a confirmed test result, an active COVID-19 infection was documented by a positive SARS-CoV-2 RNA PCR test.

The authors wrote that although 26% of the oncological healthcare workers reported symptoms potentially associated with COVID-19, only a minority had specific anti-SARS-Cov-2 antibodies. Contrary to oncological healthcare workers, anti-SARS-CoV-2 total antibodies were detected in three asymptomatic cancer patients, but were not confirmed in one patient by a second assay for anti-SARS-CoV-2 IgG antibodies. In general, the prevalence of anti-SARS-CoV-2 antibodies in oncological healthcare workers and cancer patients is low and indicates a lack of immunity against SARS-CoV-2, thus requiring continuation of strict safety measures.

Reference

Fuereder T, Berghoff AS, Heller G, et al. SARS-CoV-2 seroprevalence in oncology health care professionals and cancer patients at a tertiary care center during the COVID-19 pandemic. ESMO Open; Published online 2 September 2020. DOI: 10.1136/esmoopen-2020-000889 

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is Feasible

Targeted therapy recommendations can be made based on the molecular profiles of tumour samples from patients with metastatic malignant mesothelioma (MM) according to findings...

News digest – targeted radiation beam, precision medicine and our early detection roadmap

<img width="620" height="348" src="https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1.jpg" class="attachment-hero size-hero" alt srcset="https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1.jpg 620w, https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1-300x168.jpg 300w, https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1-220x123.jpg 220w, https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1-150x84.jpg 150w" sizes="(max-width: 620px) 100vw, 620px" data-attachment-id="18059" data-permalink="https://scienceblog.cancerresearchuk.org/2020/10/17/news-digest-targeted-radiation-beam-precision-medicine-and-our-early-detection-roadmap/radiation_hero-3/" data-orig-file="https://scienceblog.cancerresearchuk.org/wp-content/uploads/2020/10/Radiation_hero-1.jpg" data-orig-size="620,348" data-comments-opened="1"...

A Pet Pug Helped Two Sisters Realize They Both Had Breast Cancer

Sisters Amanda Tasca and Amy Niosi are grateful for one very perceptive pug. Amanda’s dog Daisy, a gift from her husband Steve and one...

Woman with Breast Cancer May Have Saved Her Twin’s Life by Revealing Her Lumpectomy Scar

When Meagan McCallum was diagnosed with breast cancer, she had no idea that her experience might actually save her sister’s life. Meagan underwent a...

Lo que debe saber sobre el cáncer de pulmón

La Dra. Jyoti D. Patel es profesora de Medicina y directora de Oncología Torácica de la Universidad de Chicago y es editora asociada para...

Alternatives for Outdoor Foods

Autumn has arrived, but that doesn’t mean outdoor dining has to end! You might be wondering what foods you could prepare that are healthy...